MedTrace Logo

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

NCT04245150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2024-09-19

No results posted yet for this study

Summary

Microorganisms in the human body (such as virus, bacteria, fungus) may have an important role in breast cancer side effects. In this study, microorganisms will be analyzed to determine which, if any,are present. It will then be determined if side effects from breast radiation are associated with these microorganisms. Understanding the association of microorganisms with side effects will allow the study team to look at strategies to reduce side effects for patients undergoing radiation to the breast.

Conditions

Interventions

OTHER

Stool sample

Stool sample

OTHER

Skin Swab Sample

Skin Swab Sample

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Chirag Shah, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-21
Primary Completion
2024-07-30
Completion
2024-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245150 on ClinicalTrials.gov